These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

409 related articles for article (PubMed ID: 29659102)

  • 1. Initial severity and antidepressant efficacy for anxiety disorders, obsessive-compulsive disorder, and posttraumatic stress disorder: An individual patient data meta-analysis.
    de Vries YA; Roest AM; Burgerhof JGM; de Jonge P
    Depress Anxiety; 2018 Jun; 35(6):515-522. PubMed ID: 29659102
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of baseline severity on antidepressant efficacy for anxiety disorders: meta-analysis and meta-regression.
    de Vries YA; de Jonge P; van den Heuvel E; Turner EH; Roest AM
    Br J Psychiatry; 2016 Jun; 208(6):515-21. PubMed ID: 26989093
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Obsessive-compulsive disorder has a reduced placebo (and antidepressant) response compared to other anxiety disorders: A meta-analysis.
    Sugarman MA; Kirsch I; Huppert JD
    J Affect Disord; 2017 Aug; 218():217-226. PubMed ID: 28477500
    [TBL] [Abstract][Full Text] [Related]  

  • 4. D-Cycloserine Augmentation of Exposure-Based Cognitive Behavior Therapy for Anxiety, Obsessive-Compulsive, and Posttraumatic Stress Disorders: A Systematic Review and Meta-analysis of Individual Participant Data.
    Mataix-Cols D; Fernández de la Cruz L; Monzani B; Rosenfield D; Andersson E; Pérez-Vigil A; Frumento P; de Kleine RA; Difede J; Dunlop BW; Farrell LJ; Geller D; Gerardi M; Guastella AJ; Hofmann SG; Hendriks GJ; Kushner MG; Lee FS; Lenze EJ; Levinson CA; McConnell H; Otto MW; Plag J; Pollack MH; Ressler KJ; Rodebaugh TL; Rothbaum BO; Scheeringa MS; Siewert-Siegmund A; Smits JAJ; Storch EA; Ströhle A; Tart CD; Tolin DF; van Minnen A; Waters AM; Weems CF; Wilhelm S; Wyka K; Davis M; Rück C; ; Altemus M; Anderson P; Cukor J; Finck C; Geffken GR; Golfels F; Goodman WK; Gutner C; Heyman I; Jovanovic T; Lewin AB; McNamara JP; Murphy TK; Norrholm S; Thuras P
    JAMA Psychiatry; 2017 May; 74(5):501-510. PubMed ID: 28122091
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Internet-Based Cognitive Behavioral Therapy With Real-Time Therapist Support via Videoconference for Patients With Obsessive-Compulsive Disorder, Panic Disorder, and Social Anxiety Disorder: Pilot Single-Arm Trial.
    Matsumoto K; Sutoh C; Asano K; Seki Y; Urao Y; Yokoo M; Takanashi R; Yoshida T; Tanaka M; Noguchi R; Nagata S; Oshiro K; Numata N; Hirose M; Yoshimura K; Nagai K; Sato Y; Kishimoto T; Nakagawa A; Shimizu E
    J Med Internet Res; 2018 Dec; 20(12):e12091. PubMed ID: 30559094
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Failure to Respond after Reinstatement of Antidepressant Medication: A Systematic Review.
    Bosman RC; Waumans RC; Jacobs GE; Oude Voshaar RC; Muntingh ADT; Batelaan NM; van Balkom AJLM
    Psychother Psychosom; 2018; 87(5):268-275. PubMed ID: 30041180
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A pilot study of vagus nerve stimulation (VNS) for treatment-resistant anxiety disorders.
    George MS; Ward HE; Ninan PT; Pollack M; Nahas Z; Anderson B; Kose S; Howland RH; Goodman WK; Ballenger JC
    Brain Stimul; 2008 Apr; 1(2):112-21. PubMed ID: 20633378
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cognitive behavioral therapy for anxiety and related disorders: A meta-analysis of randomized placebo-controlled trials.
    Carpenter JK; Andrews LA; Witcraft SM; Powers MB; Smits JAJ; Hofmann SG
    Depress Anxiety; 2018 Jun; 35(6):502-514. PubMed ID: 29451967
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative efficacy of antidepressants in preventing relapse in anxiety disorders - a meta-analysis.
    Donovan MR; Glue P; Kolluri S; Emir B
    J Affect Disord; 2010 Jun; 123(1-3):9-16. PubMed ID: 19616306
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spotlight on paroxetine in psychiatric disorders in adults.
    Wagstaff AJ; Cheer SM; Matheson AJ; Ormrod D; Goa KL
    CNS Drugs; 2002; 16(6):425-34. PubMed ID: 12027788
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Place of Antipsychotics in the Therapy of Anxiety Disorders and Obsessive-Compulsive Disorders.
    Pignon B; Tezenas du Montcel C; Carton L; Pelissolo A
    Curr Psychiatry Rep; 2017 Nov; 19(12):103. PubMed ID: 29110139
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Associations between severity of anxiety and clinical and biological features of major affective disorders.
    Cavicchioli FL; Maes M; Roomruangwong C; Bonifacio KL; Barbosa DS; Anderson G; Vargas HO; Nunes SOV
    Psychiatry Res; 2018 Feb; 260():17-23. PubMed ID: 29156296
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The association between obsessive compulsive disorder and obsessive compulsive personality disorder: prevalence and clinical presentation.
    Gordon OM; Salkovskis PM; Oldfield VB; Carter N
    Br J Clin Psychol; 2013 Sep; 52(3):300-15. PubMed ID: 23865406
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neurostimulation in Anxiety Disorders, Post-traumatic Stress Disorder, and Obsessive-Compulsive Disorder.
    Freire RC; Cabrera-Abreu C; Milev R
    Adv Exp Med Biol; 2020; 1191():331-346. PubMed ID: 32002936
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Duration of untreated illness in a cross-diagnostic sample of obsessive-compulsive disorder, panic disorder, and social anxiety disorder.
    Vigne P; Fortes P; Dias RV; Laurito LD; Loureiro CP; de Menezes GB; Stangier U; Fontenelle LF
    CNS Spectr; 2019 Oct; 24(5):526-532. PubMed ID: 30419984
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical response and risk for reported suicidal ideation and suicide attempts in pediatric antidepressant treatment: a meta-analysis of randomized controlled trials.
    Bridge JA; Iyengar S; Salary CB; Barbe RP; Birmaher B; Pincus HA; Ren L; Brent DA
    JAMA; 2007 Apr; 297(15):1683-96. PubMed ID: 17440145
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The relationship between obsessive-compulsive disorder and anxiety disorders: A question of diagnostic boundaries or simply severity of symptoms?
    Vigne P; Simões BFT; de Menezes GB; Fortes PP; Dias RV; Laurito LD; Loureiro CP; Moreira-de-Oliveira ME; Albertella L; Lee RSC; Stangier U; Fontenelle LF
    Compr Psychiatry; 2019 Oct; 94():152116. PubMed ID: 31421287
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of typical and atypical antipsychotics for primary and comorbid anxiety symptoms or disorders: a review.
    Gao K; Muzina D; Gajwani P; Calabrese JR
    J Clin Psychiatry; 2006 Sep; 67(9):1327-40. PubMed ID: 17017818
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential efficacy of memantine for obsessive-compulsive disorder vs. generalized anxiety disorder: an open-label trial.
    Feusner JD; Kerwin L; Saxena S; Bystritsky A
    Psychopharmacol Bull; 2009; 42(1):81-93. PubMed ID: 19204653
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 21.